HMGCS2 and prostate adenocarcinoma: Interestingly, in our univariable time‐to‐recurrence analysis in the TCGA-PRAD dataset, a positive association of increased expression of ACAT1, OXCT1 & BDH1 and decreased HMGCL & HMGCS2 with PCa progression was observed.